AMRUTANJANNSEAmrutanjan Health Care Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 9 Apr · 14:16 IST

S. Sambhu Prasad has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

AMRUTANJAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.0%1-day move
₹530.00
prior close
₹531.15
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.1-0.1-0.2+1.0-1.7+0.2+1.9+3.8+7.4+7.5+2.3+6.4+1.1
Up moveDown movePending
AI summary

S. Sambhu Prasad, Chairman and Managing Director of Amrutanjan Health Care Limited, has filed an annual disclosure confirming that he, along with persons acting in concert (PAC), has not created any encumbrance — directly or indirectly — over any of his shares as of 31 March 2026. The filing is made pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Two related entities — Kasinadhuni Nageswara Rao Sivalenka Sambhuprasad Dharma Nidhi (Managing Trustee) and Good Health Holdings Private Limited (Director: S. Sambhu Prasad) — also filed identical nil-encumbrance declarations on the same date. This is a mandatory annual compliance filing for promoters holding above a certain threshold.

Likely market impact

The nil encumbrance declaration is a positive signal for minority shareholders as it indicates the promoter group has not pledged shares to raise debt, reducing risk of forced selling or sudden supply overhang in the market.